Triple
T77840
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | American Association for Cancer Research |
E1556
|
entity |
| Predicate | publishes |
P80
|
FINISHED |
| Object |
Cancer Immunology Research
Cancer Immunology Research is a peer-reviewed scientific journal focusing on research at the intersection of immunology and cancer biology, including cancer immunotherapy and tumor-immune system interactions.
|
E8257
|
NE FINISHED |
How this triple was built (4 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cancer Immunology Research | Statement: [American Association for Cancer Research, publishes, Cancer Immunology Research]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Cancer Immunology Research Context triple: [American Association for Cancer Research, publishes, Cancer Immunology Research]
-
A.
Cancer Research
Cancer Research is a leading peer-reviewed scientific journal that publishes significant findings in oncology, including basic, translational, and clinical cancer research.
-
B.
Clinical Cancer Research
Clinical Cancer Research is a peer-reviewed medical journal focusing on innovative clinical and translational research in oncology.
-
C.
Cancer Discovery
Cancer Discovery is a leading peer-reviewed scientific journal that publishes cutting-edge research and clinical studies in oncology.
-
D.
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics is a peer-reviewed scientific journal focusing on the discovery, development, and clinical evaluation of novel cancer therapeutics.
-
E.
Cancer Prevention Research
Cancer Prevention Research is a peer-reviewed scientific journal focusing on research aimed at understanding, preventing, and intercepting cancer development.
- F. None of above. chosen
- G. Unsure - the case is ambiguous/there is not enough information to decide.
NEDg
Description generation
gpt-5.1
Instruction
Generate a one-sentence description of the target entity. You are given a context triple in the form (subject, predicate, object), where the object is the target entity. # Instructions Use the triple to infer relevant information about the entity. Describe the entity based on what is most defining, well-known. Avoid repeating the information from the triple, unless really essential. # Response Format Return only the sentence: "Description: [one-sentence description of the target entity]"
Input
Entity: Cancer Immunology Research Triple: [American Association for Cancer Research, publishes, Cancer Immunology Research]
Generated description
Cancer Immunology Research is a peer-reviewed scientific journal focusing on research at the intersection of immunology and cancer biology, including cancer immunotherapy and tumor-immune system interactions.
NED2
Entity disambiguation (via description)
gpt-5-mini-2025-08-07
Target entity: Cancer Immunology Research Target entity description: Cancer Immunology Research is a peer-reviewed scientific journal focusing on research at the intersection of immunology and cancer biology, including cancer immunotherapy and tumor-immune system interactions.
-
A.
Cancer Research
Cancer Research is a leading peer-reviewed scientific journal that publishes significant findings in oncology, including basic, translational, and clinical cancer research.
-
B.
Clinical Cancer Research
Clinical Cancer Research is a peer-reviewed medical journal focusing on innovative clinical and translational research in oncology.
-
C.
Cancer Discovery
Cancer Discovery is a leading peer-reviewed scientific journal that publishes cutting-edge research and clinical studies in oncology.
-
D.
Molecular Cancer Therapeutics
Molecular Cancer Therapeutics is a peer-reviewed scientific journal focusing on the discovery, development, and clinical evaluation of novel cancer therapeutics.
-
E.
Cancer Prevention Research
Cancer Prevention Research is a peer-reviewed scientific journal focusing on research aimed at understanding, preventing, and intercepting cancer development.
- F. None of above. chosen
Provenance (5 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69a24c60d19c8190a1b6c105ca59ef5b |
completed | Feb. 28, 2026, 2:01 a.m. |
| NER | Named-entity recognition | batch_69a24f30e5848190a8edcb37c356ce0a |
completed | Feb. 28, 2026, 2:13 a.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69a26241d4c08190885dab6aef75dcf3 |
completed | Feb. 28, 2026, 3:34 a.m. |
| NEDg | Description generation | batch_69a26319b2b0819080ae6aeec36bc6e3 |
completed | Feb. 28, 2026, 3:38 a.m. |
| NED2 | Entity disambiguation (via description) | batch_69a263a07dfc8190a9acf5118f2a68f1 |
completed | Feb. 28, 2026, 3:40 a.m. |
Created at: Feb. 28, 2026, 2:06 a.m.